Yokom DW, Stewart J, Alimohamed NS, Winquist E, Barry S, Hubay S, Lattouf J-B, Leonard H, Girolametto C, Saad F, Sridhar SS. Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. CUAJ [Internet]. 2018 Mar. 26 [cited 2024 Apr. 25];12(8). Available from: https://cuaj.ca/index.php/journal/article/view/5108